Search Results - "Guvakova, Marina A"

Refine Results
  1. 1

    The g3mclass is a practical software for multiclass classification on biomarkers by Guvakova, Marina A., Sokol, Serguei

    Published in Scientific reports (05-11-2022)
    “…The analytes qualified as biomarkers are potent tools to diagnose various diseases, monitor therapy responses, and design therapeutic interventions. The early…”
    Get full text
    Journal Article
  2. 2

    The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I by Guvakova, Marina A, Lee, William S Y, Furstenau, Dana K, Prabakaran, Indira, Li, David C, Hung, Rupert, Kushnir, Natasha

    Published in Biochemical journal (15-10-2014)
    “…The Ras-related GTPase Rap1 promotes cell adhesion and migration. Although the significance of Rap1 contribution to cell migration is increasingly being…”
    Get more information
    Journal Article
  3. 3

    Automated Classification of Breast Cancer Across the Spectrum of ERBB2 Expression Focusing on Heterogeneous Tumors With Low Human Epidermal Growth Factor Receptor 2 Expression by Guvakova, Marina A

    Published in JCO clinical cancer informatics (01-07-2023)
    “…Although pharmaceutical companies conduct clinical trials of novel human epidermal growth factor receptor 2 (HER2)-low-directed drugs, diagnosing HER2-low…”
    Get more information
    Journal Article
  4. 4

    Gaussian Mixture Models for Probabilistic Classification of Breast Cancer by Prabakaran, Indira, Wu, Zhengdong, Lee, Changgun, Tong, Brian, Steeman, Samantha, Koo, Gabriel, Zhang, Paul J, Guvakova, Marina A

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…In the era of omics-driven research, it remains a common dilemma to stratify individual patients based on the molecular characteristics of their tumors. To…”
    Get full text
    Journal Article
  5. 5

    Improving patient classification and biomarker assessment using Gaussian Mixture Models and Bayes' rule by Guvakova, Marina A

    Published in Oncoscience (01-11-2019)
    “…In clinical research, determining cutoff values for continuous variables in test results remains challenging, particularly when considering candidate…”
    Get full text
    Journal Article
  6. 6

    Insulin-like growth factors control cell migration in health and disease by Guvakova, Marina A.

    “…Insulin-like growth factors I and II (IGF-I and IGF-II) have an ancient origin and play essential roles in fundamental biological processes. Although IGFs are…”
    Get full text
    Journal Article
  7. 7

    Rap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer by Grau, Jillian R., Lewis, Robert, Fraker, Douglas L., Guvakova, Marina A., Prabakaran, Indira

    Published in Journal of Thyroid Research (01-01-2011)
    “…The development of molecular biomarkers (BMs) of follicular thyroid carcinoma is aimed at advancing diagnosis of follicular neoplasm, as histological…”
    Get full text
    Journal Article
  8. 8

    CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ by Guvakova, Marina A., Prabakaran, Indira, Wu, Zhengdong, Hoffman, Daniel I., Huang, Ye, Tchou, Julia, Zhang, Paul J.

    Published in Breast cancer research and treatment (01-09-2020)
    “…Purpose This proof-of-concept study investigates gene expression in core needle biopsies (CNB) to predict whether individuals diagnosed with ductal carcinoma…”
    Get full text
    Journal Article
  9. 9

    Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ by Furstenau, Dana K., Mitra, Nandita, Wan, Fei, Lewis, Robert, Feldman, Michael D., Fraker, Douglas L., Guvakova, Marina A.

    Published in Breast cancer research and treatment (01-09-2011)
    “…Currently, there are no applied molecular markers to aid in predicting risk of carcinoma in situ (CIS) progression to invasive cancer, and therefore, all women…”
    Get full text
    Journal Article
  10. 10

    Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells by GUVAKOVA, M. A, SURMACZ, E

    Published in Cancer research (Chicago, Ill.) (01-07-1997)
    “…The insulin-like growth factor I receptor (IGF-IR) is involved in the control of breast cancer cell growth. The cytostatic activity of tamoxifen (Tam), a…”
    Get full text
    Journal Article
  11. 11

    Functional role of alpha-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells by Guvakova, Marina A, Adams, Josephine C, Boettiger, David

    Published in Journal of cell science (01-11-2002)
    “…Within epithelial tissue, cells are held together by specialized lateral junctions. At particular stages of development and in pathological processes such as…”
    Get full text
    Journal Article
  12. 12

    The Activated Insulin-Like Growth Factor I Receptor Induces Depolarization in Breast Epithelial Cells Characterized by Actin Filament Disassembly and Tyrosine Dephosphorylation of FAK, Cas, and Paxillin by Guvakova, Marina A., Surmacz, Ewa

    Published in Experimental cell research (25-08-1999)
    “…Insulin-like growth factor I (IGF-I) promotes the motility of different cell types. We investigated the role of IGF-I receptor (IGF-IR) signaling in locomotion…”
    Get full text
    Journal Article
  13. 13

    Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ by Jiang, YunQing, Prabakaran, Indira, Wan, Fei, Mitra, Nandita, Furstenau, Dana K, Hung, Rupert K, Cao, Siyuan, Zhang, Paul J, Fraker, Douglas L, Guvakova, Marina A

    Published in Biomarker research (28-11-2014)
    “…A subset of patients with ductal carcinoma in situ (DCIS) will develop invasive breast cancer (IBC). To date, there are no effective predictive biomarkers for…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-I receptor by Guvakova, Marina A., Boettiger, David, Adams, Josephine C.

    “…Insulin-like growth factor-I receptor (IGF-IR) signaling contributes to the formation of mammary carcinomas and has chiefly been studied with regard to the…”
    Get full text
    Journal Article
  16. 16

    Type I insulin-like growth factor receptor function in breast cancer by Surmacz, E, Guvakova, M A, Nolan, M K, Nicosia, R F, Sciacca, L

    Published in Breast cancer research and treatment (01-02-1998)
    “…Experimental evidence suggests an important role of the type I IGF receptor (IGF-IR) in breast cancer development. Breast tumors and breast cancer cell lines…”
    Get full text
    Journal Article
  17. 17

    Abstract 5283: Vav2 oncoprotein up regulation may predict the aggressive subtype of ductal carcinoma in situ by Guvakova, Marina A., Jiang, Yun Qing, Prabakaran, Indira, Wan, Fei, Mitra, Nandita, Zhang, Paul J., Fraker, Douglas L.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Background: A subset of patients with ductal carcinoma in situ (DCIS) will develop invasive breast cancer (IBC). To date, there are no effective…”
    Get full text
    Journal Article
  18. 18

    Insulin-like Growth Factor I Controls Adhesion Strength Mediated by α5β1 Integrins in Motile Carcinoma Cells by Lynch, Laura, Vodyanik, Pavel I., Boettiger, David, Guvakova, Marina A.

    Published in Molecular biology of the cell (01-01-2005)
    “…One of the intriguing questions regarding cell motility concerns the mechanism that makes stationary cells move. Here, we provide the first physical evidence…”
    Get full text
    Journal Article
  19. 19

    Abstract B40: The quest for biomarkers of progressive DCIS using archived tissue by Guvakova, Marina A., Jiang, YunQing, Prabakaran, Indira, Wan, Fei, Mitra, Nandita, Fraker, Douglas L., Zhang, Paul J.

    Published in Molecular cancer therapeutics (01-11-2013)
    “…Abstract Background: Presently, an indolent ductal carcinoma in situ (DCIS) cannot be distinguished from a progressive tumor, making the appropriate treatment…”
    Get full text
    Journal Article
  20. 20

    High frequency of tumour cell reversion to non-tumorigenic phenotype by Lavrovsky, V A, Guvakova, M A, Lavrovsky, Y V

    Published in European journal of cancer (1990) (1992)
    “…Nine spontaneously transformed cell lines were isolated from embryo fibroblasts of mice and rats with different genotypes. In six cell lines highly tumorigenic…”
    Get more information
    Journal Article